For those of you who may not be familiar with them, The Onion is a satirical website that mimics a newspaper or news-site. The Onion originated 20+ years ago as a fake newspaper, started by (I think) students at the University of Wisconsin.
They've continued over the years, and for several years have been publishing a website.
I popped by there today and found a headline: "Latest Study Finds Cancer Calls Now Cruelly Mocking Researchers." Related articles include "98% of Babies Manic Depressive" and "Doctors Closing In On 'Second Head-Bonk' Amnesia Cure'".
Anyhow, the article in question is not only funny but also pretty well researched. For example:
"The report confirmed that while all types of carcinomas are beginning to make researchers feel like garbage, myeloma cancer cells in particular think they're God's gift just because they're resistant to the frontline drug Velcade."
Bad language abounds, but for those not offended by such things, this is definitely chuckle-inducing.
http://www.theonion.com/articles/latest-study-finds-cancer-cells-now-cruelly-mockin,30074/
Wednesday, October 24, 2012
Tuesday, October 23, 2012
Myeloma Cure Panel Discussion: Cure versus Control
Hello folks.
On Monday, October 29th, I will be participating in my second panel discussion organized by Curetalk, an organization that hosts a number of dialogues related to cancer therapies. I spoke on one of these a few weeks ago and was going to post about it here but my comments were overtaken by other events that I wanted to cover.
At any rate, I'm going to participate next week along with some other panelists including fellow Myeloma blogger Pat Killingsworth. The tantalizingly controversial topic is, as noted above, cure versus control.
After we tackle that, we will address other questions such as "which is the one true God?" and "the definitive, simple solution to lasting peace in the Middle East."
The conference call, which is free to join, is limited to 50 callers, all of whom can ask questions of the panelists. I urge those of you interested to register through the following link.
http://trialx.com/curetalk/panels/myeloma-cure-panel-29th-october-2012-7pm-est-on-cure-vs-control-co-host-pat-killingsworth/
For me, I'm very excited to participate in the discussion. I will, however, be calling in from the airport in Las Vegas at the end of a much-needed mini-vacation. I will try to find a quiet spot populated by people in the fetal position, listlessly searching their pockets for their once-full wallets.
In other news...Velcade Sub-Q has (thus far) the same side-effects as intravenous Velcade for me, with the added negative of painful bruising at the injection sites, reminiscent of Neupogen shots. I am strongly considering switching back to IV Velcade -- they have to tap the port to check blood anyway...
Anybody have experience / thoughts on this?
Have a good week, everybody!
On Monday, October 29th, I will be participating in my second panel discussion organized by Curetalk, an organization that hosts a number of dialogues related to cancer therapies. I spoke on one of these a few weeks ago and was going to post about it here but my comments were overtaken by other events that I wanted to cover.
At any rate, I'm going to participate next week along with some other panelists including fellow Myeloma blogger Pat Killingsworth. The tantalizingly controversial topic is, as noted above, cure versus control.
After we tackle that, we will address other questions such as "which is the one true God?" and "the definitive, simple solution to lasting peace in the Middle East."
The conference call, which is free to join, is limited to 50 callers, all of whom can ask questions of the panelists. I urge those of you interested to register through the following link.
http://trialx.com/curetalk/panels/myeloma-cure-panel-29th-october-2012-7pm-est-on-cure-vs-control-co-host-pat-killingsworth/
For me, I'm very excited to participate in the discussion. I will, however, be calling in from the airport in Las Vegas at the end of a much-needed mini-vacation. I will try to find a quiet spot populated by people in the fetal position, listlessly searching their pockets for their once-full wallets.
In other news...Velcade Sub-Q has (thus far) the same side-effects as intravenous Velcade for me, with the added negative of painful bruising at the injection sites, reminiscent of Neupogen shots. I am strongly considering switching back to IV Velcade -- they have to tap the port to check blood anyway...
Anybody have experience / thoughts on this?
Have a good week, everybody!
Monday, October 8, 2012
BD consult
Okay, on to more positive things.
After a couple of scheduling snafus, I was able to speak with BD, a long-time eader in MM research and therapy. He was one of my original consults when I was diagnosed and I thought the current end-of-protocol-decision-point would be a good time to reconnect with him. I was able to approach this with considerably less trepidation than would have been the case before getting the good news about my MYC gene a few weeks ago, so it was an almost philosophical conversation about when to end maintenance.
Highlights:
* I am doing very well.
* He observes that getting to four years of CR in the Total Therapy program is a meaningful achievement in terms of there being a flattening of the survival curve. Readers will note I have mentioned this before. I've got about ten more months. For whatever reason, BB would have been okay taking me off therapy at three years of CR if those pits were gone, but as they're not, we continue.
* He suggested that Zometa will not cause those pits to heal up -- Zometa stops osteoclasts from destroying bones, but it doesn't accelerate healing. So that means no more bisphosphonates needed.
* He believes, unlike KA, that I shouldn't be on proteasome inhibitors forever -- even if they become a simple oral alternative. Rather, I need to get off all this stuff to allow the body to heal. He noted the squamous cell carcinoma in the finger is an example of my body having been pushed to its limits by the therapy and I don't disagree.
* Having said that, he believes single-agent Velcade is not a bad idea until the pits clear up, which could take quite some time.
* He thought Interferon wouldn't do anything, though as I pointed out BB's musings about this were before we saw the normalized expression of the MYC gene.
* He thought radiation of the four pits could be a possibility in the event there are any rogue cells in there...but he also thought that without any evidence of the disease, it wouldn't be worth it, and he further noted that radiation impedes the healing process.
All in all, his hope would be that I could get off Velcade in the next 3-6 months, pending the results of MRI/PET that would show the pits are gone completely. As I'm going back to UAMS in March, that is a logical time to stop the Velcade if I'm able to do so -- but I want to wait until those pits are straightened out first.
On the strength of this and the normalized MYC, I'm feeling like I may not need my third "second opinion", which was to come from MAYO Scottsdale and a doctor there who specializes in MYC. That's scheduled for this Thursday but it can only be done in-person and for anybody that knows my job, it's a real pain to get time off to do anything. They give me time to go to Arkansas twice a year now and I appreciate that much -- taking off more time seems like it may not be critical.
I shall have to think about it!
After a couple of scheduling snafus, I was able to speak with BD, a long-time eader in MM research and therapy. He was one of my original consults when I was diagnosed and I thought the current end-of-protocol-decision-point would be a good time to reconnect with him. I was able to approach this with considerably less trepidation than would have been the case before getting the good news about my MYC gene a few weeks ago, so it was an almost philosophical conversation about when to end maintenance.
Highlights:
* I am doing very well.
* He observes that getting to four years of CR in the Total Therapy program is a meaningful achievement in terms of there being a flattening of the survival curve. Readers will note I have mentioned this before. I've got about ten more months. For whatever reason, BB would have been okay taking me off therapy at three years of CR if those pits were gone, but as they're not, we continue.
* He suggested that Zometa will not cause those pits to heal up -- Zometa stops osteoclasts from destroying bones, but it doesn't accelerate healing. So that means no more bisphosphonates needed.
* He believes, unlike KA, that I shouldn't be on proteasome inhibitors forever -- even if they become a simple oral alternative. Rather, I need to get off all this stuff to allow the body to heal. He noted the squamous cell carcinoma in the finger is an example of my body having been pushed to its limits by the therapy and I don't disagree.
* Having said that, he believes single-agent Velcade is not a bad idea until the pits clear up, which could take quite some time.
* He thought Interferon wouldn't do anything, though as I pointed out BB's musings about this were before we saw the normalized expression of the MYC gene.
* He thought radiation of the four pits could be a possibility in the event there are any rogue cells in there...but he also thought that without any evidence of the disease, it wouldn't be worth it, and he further noted that radiation impedes the healing process.
All in all, his hope would be that I could get off Velcade in the next 3-6 months, pending the results of MRI/PET that would show the pits are gone completely. As I'm going back to UAMS in March, that is a logical time to stop the Velcade if I'm able to do so -- but I want to wait until those pits are straightened out first.
On the strength of this and the normalized MYC, I'm feeling like I may not need my third "second opinion", which was to come from MAYO Scottsdale and a doctor there who specializes in MYC. That's scheduled for this Thursday but it can only be done in-person and for anybody that knows my job, it's a real pain to get time off to do anything. They give me time to go to Arkansas twice a year now and I appreciate that much -- taking off more time seems like it may not be critical.
I shall have to think about it!
Quick post on the Beacon drama
No good deed, it has been said, goes unpunished.
And how.
A doctor from another institution recently published an article calling into question the mortality statistics from UAMS. Essentially this article didn't dispute the percent of patients who were still alive at a given point in time (UAMS' strong suit) but it disputed the percent of patients whose cause of death was reported as "unknown/undetermined" instead of treatment-related. He accused UAMS, essentially, of downplaying the percent of patients that die from the toxicity of the program.
UAMS is defending itself, though frankly not as aggressively as I'd like. It's uncommon, I believe, for doctors to wage public war over stuff like this but this episode has certainly given those opposed to BB for whatever reason an excuse to vent their spleens.
I went to the Myeloma Beacon website after have been warned of some of this by BJ -- and I feel I owe a little something to BB and the team since they've saved my life.
I ended up stepping into a snake pit over there. I've already over-participated in the thread so I won't be posting anything further there but I have an observation and a request.
Observation: the fact that people with a life-threatening disease don't have better things to do than denigrating both those working against the disease and those patients who choose a different treatment plan than their own would be mind-boggling were it not so depressing.
Request: For any of you who read this blog and are "offended" when I point out that BB used particular protocols before they were generally accepted...do us both a favor and stop reading this blog. It wasn't meant for you and we'll both be happier.
Subscribe to:
Posts (Atom)
